ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China · Delayed Price · Currency is CNY 8.32
-0.31 (-3.59%)
At close: Jun 2, 2026
ChemPartner PharmaTech Revenue
In the year 2025, ChemPartner PharmaTech had annual revenue of 1.13B CNY with 16.96% growth. ChemPartner PharmaTech had revenue of 266.69M in the quarter ending March 31, 2026, with 2.08% growth.
Revenue
1.13B
Revenue Growth
+16.96%
P/S Ratio
3.65
Revenue / Employee
625.53K
Employees
1,814
Market Cap
4.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.13B | 164.51M | 16.96% |
| Dec 31, 2024 | 970.20M | -168.16M | -14.77% |
| Dec 31, 2023 | 1.14B | -188.22M | -14.19% |
| Jan 1, 2023 | 1.33B | -364.09M | -21.54% |
| Jan 1, 2022 | 1.69B | 209.09M | 14.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Hvsen Biotechnology | 1.74B |
| Kexing Biopharm | 1.46B |
| Beijing Bohui Innovation Biotechnology Group | 812.78M |
| Lifecome Biochemistry | 502.95M |
| Assure Tech (Hangzhou) | 409.48M |
| Beijing Scitop Bio-tech | 373.31M |
| Jiangsu Bioperfectus Technologies | 326.02M |
| Shanghai Obio Technology (Group) Corp. | 265.39M |